Core Viewpoint - Sow Good Inc. has completed a series of strategic transactions aimed at enhancing its liquidity, transitioning to a more asset-light model, and exploring growth opportunities in the candy business while evaluating broader strategic alternatives [1]. Financing and Capital Structure - The company entered into a $6.0 million private placement agreement with investor David Lazar, structured in two tranches of $3.0 million each through the issuance of Series AA and Series AAA Convertible Non-Redeemable Preferred Stock [2]. - The first tranche of $3.0 million was completed on December 31, 2025, with the second tranche expected to close before March 31, 2026, pending stockholder approvals [3]. Asset Management and Strategic Transactions - Sow Good sold a significant portion of its freeze-dried snacks and candy business assets to Trea Grove, LLC for $1.5 million, payable in installments through March 31, 2026 [5]. - A distribution agreement was established with Trea Grove, LLC, appointing them as the exclusive distributor for certain products until July 31, 2026, with the distributor managing various operational aspects and remitting 10% of gross receipts to the company [6]. Business Operations and Future Strategy - The transactions do not indicate a liquidation; the company will continue its candy business operations [7]. - The transition allows Sow Good to remain active in the candy market while significantly reducing fixed operating costs, positioning the company for growth opportunities and strategic assessments [8]. Leadership Changes - David Lazar has been appointed as Chief Executive Officer and Chair of the Board, while Claudia Goldfarb remains as Chief Operating Officer [10]. - Several board members have changed, with new appointments and resignations occurring in connection with the recent transactions [10]. Strategic Focus - Following these transactions, the company will continue to operate its candy business and assess growth opportunities within the candy and snack industry, including potential partnerships and acquisitions to strengthen its financial position [11].

Core Viewpoint - Ekso Bionics Holdings, Inc. reported a revenue rebound and improved financial metrics for Q3 2025, indicating successful navigation through previous challenges and a focus on growth strategy while managing resources [3][10]. Financial Performance - For Q3 2025, the company recorded revenue of $4.2 million, a 2% increase year-over-year from $4.1 million in Q3 2024, and a 105% sequential increase from $2.1 million in Q2 2025 [3][10]. - Gross profit for Q3 2025 was $2.5 million, with a gross margin of approximately 60.3%, up from $2.2 million and 53.5% in Q3 2024, driven by higher margin Enterprise Health sales and lower device costs [4][10]. - Net loss for Q3 2025 was $1.4 million, or $0.54 per share, representing a 31% improvement from a net loss of $2.1 million, or $1.53 per share, in Q3 2024 [7][10]. Expense Management - Sales and marketing expenses decreased to $1.3 million in Q3 2025 from $1.8 million in Q3 2024, primarily due to lower payroll expenses related to the Employee Retention Credit [5]. - Research and development expenses were reduced to $0.6 million in Q3 2025 from $0.8 million in Q3 2024, also due to lower payroll expenses and headcount [6]. - General and administrative expenses decreased to $2.1 million in Q3 2025 from $2.3 million in Q3 2024, attributed to lower payroll expenses, partially offset by higher legal costs [7]. Strategic Initiatives - The company is exploring strategic transactions, which may include acquiring a business in a different industry or selling its current business, with no assurances that any transaction will occur [9][11]. - The company launched eksoUniversity and delivered its first official CEU certification to a physical therapist in Connecticut [10]. Cash Position - As of September 30, 2025, the company had cash of $2.7 million, down from $4.5 million at the end of 2024 [8][15]. Balance Sheet Overview - Total assets as of September 30, 2025, were $21.7 million, a decrease from $26.7 million at the end of 2024 [15]. - Total liabilities were $12.0 million, down from $13.9 million at the end of 2024, while stockholders' equity decreased to $9.7 million from $12.7 million [15].

As filed with the U.S. Securities and Exchange Commission on September 1, 2023 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 WiSA Technologies, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Delaware 3674 30-1135279 (I.R.S. Employer Identification Number) (Name, address, including zip code, an ...